Promatek Industries, Ltd. v. Equitrac Corporation

300 F.3d 808, 63 U.S.P.Q. 2d (BNA) 2018, 2002 U.S. App. LEXIS 16207, 2002 WL 1837776
CourtCourt of Appeals for the Seventh Circuit
DecidedAugust 13, 2002
Docket00-4276
StatusPublished
Cited by118 cases

This text of 300 F.3d 808 (Promatek Industries, Ltd. v. Equitrac Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Promatek Industries, Ltd. v. Equitrac Corporation, 300 F.3d 808, 63 U.S.P.Q. 2d (BNA) 2018, 2002 U.S. App. LEXIS 16207, 2002 WL 1837776 (7th Cir. 2002).

Opinion

WILLIAMS, Circuit Judge.

This appeal concerns the propriety of a preliminary injunction in which one competitor, Promatek, prevailed against another, Equitrac. The preliminary injunction was issued without a hearing and Equitrac had to place language on its web page to remedy violations of the Lanham Act. Equitrac now appeals that order and because the district court did not abuse its discretion, we affirm.

I. BACKGROUND

Promatek and Equitrac are competitors in selling cost-recovery equipment. Equit-rac’s marketing department advised its web designer that certain words and phrases should be used as metatags for Equitrac’s website. 1 In response, the web designer placed the term “Copitrack” in the contents of Equitrac’s website as a metatag. Equitrac used the term as a metatag because it provides maintenance and service on Copitrak equipment, a product used in the cost-recovery busi *811 ness. 2 Promatek holds the trademark for Copitrak, and once it learned of Equitrac’s use of the term Copitrack in the metatag, it brought suit. After learning of Proma-tek’s suit, Equitrac contacted all of the search engines known to it and requested that they remove any link between the term Copitrack and Equitrac’s website. Equitrac also removed the Copitrack me-tatag from its website.

Not satisfied with Equitrac’s remedial measures, Promatek sought a preliminary injunction preventing Equitrac from using the term Copitrack in its website. After receiving materials submitted by both parties, the district court granted Promatek’s motion for preliminary injunction. Under the terms of the injunction, Equitrac was directed to place language on its web page informing consumers that any link between its website and Copitrack was in error:

If you were directed to this site through the term “Copitrack,” that is in error as there is no affiliation between Equitrac and that term. The mark “Copitrak” is a registered trademark of Promatek Industries, Ltd., which can be found at www.promatek.com or www.copit-rak.com.

(Equitrac Ex. 1, Prelim. Inj. Order at 5).

Equitrac appeals the issuance of the injunction, arguing that the ordered language will not only inform consumers of its competitor, Promatek, but will encourage people to go to Promatek’s website. Pro-matek counters that without this language, Equitrac will continue to benefit, to Pro-matek’s detriment, from consumer internet searches containing the word Copitrack. We conclude that the district court was correct in finding Promatek would suffer a greater harm than Equitrac if corrective measures were not taken, and we affirm the grant of the preliminary injunction.

II. ANALYSIS

A party seeking a preliminary injunction is required to demonstrate a likelihood of success on the merits, that it has no adequate remedy at law, and that it will suffer irreparable harm if the relief is not granted. Ty, Inc. v. Jones Group, 237 F.3d 891, 895 (7th Cir.2001) (citing Abbott Labs. v. Mead Johnson & Co., 971 F.2d 6, 11 (7th Cir.1992)). If the moving party can satisfy these conditions, the court must then consider any irreparable harm an injunction would cause the nonmoving party. Ty, 237 F.3d at 895. Finally, the court must consider any consequences to the public from denying or granting the injunction. Id. Sitting as a court of equity, the court then weighs all these factors employing a sliding-scale approach. Abbott Labs., 971 F.2d at 12. That is, the more likely the plaintiffs chance of success on the merits, the less the balance of harms need weigh in its favor. Id. We review the grant of a preliminary injunction for an abuse of discretion, giving great deference to the district court’s weighing of the factors and will reverse only when the district court commits a clear error of fact or law. Ty, 237 F.3d at 896.

A. The District Court Was Correct in Granting the Injunction

1. Likelihood of success on the merits

Equitrac argues that because there was no likelihood of success on the merits of Promatek’s Lanham Act claim, the district court erred in granting the preliminary injunction. In order to prevail under *812 the Lanham Act, 15 U.S.C. § 1125(a), Pro-matek must establish that Copitrak is a protectable trademark and that Equitrac’s use of the term is likely to cause confusion among consumers. See Ty, 237 F.3d at 897. Preregistration of Promatek’s Copitrak trademark is prima facie evidence of the mark’s validity, see Publications Int’l, Ltd. v. Landoll, Inc., 164 F.3d 337, 340 (7th Cir.1998), which Equitrac does not dispute. Therefore, we turn to the issue of whether consumers would be confused by Equitrac’s use of Copitrak as a meta-tag.

In assessing the likelihood of consumer confusion, we consider: (1) the similarity between the marks in appearance and suggestion, (2) the similarity of the products, (3) the area and manner of concurrent use of the products, (4) the degree of care likely to be exercised by consumers, (5) the strength of the plaintiffs marks, (6) any evidence of actual confusion, and (7) the defendant’s intent to palm off its goods as those of the plaintiffs. Ty, 237 F.3d at 897-98. None of these factors are dispositive and the proper weight given to each will vary in each case. Id. However, the similarity of the marks, the defendant’s intent, and evidence of actual confusion are of particular importance. Id.

Given these factors, it is clear that Pro-matek has a fair likelihood of succeeding on the merits of its Lanham Act claim. Although Promatek has not provided us with evidence regarding the strength of its Copitrak mark or evidence of any actual consumer confusion, the other factors weigh in its favor. First, not only are the marks Copitrack and Copitrak similar, Equitrac admits that it meant to use the correct spelling of Copitrak in its metatag. Second, Equitrac’s use of Copitrack refers to Promatek’s registered trademark, Cop-itrak. Additionally, Equitrac and Proma-tek are direct competitors in the cost-recovery and cost-control equipment and services market. Most importantly, for purposes of this case, however, is the degree of care to be exercised by consumers.

Although Equitrac claims that it did not intend to mislead consumers with respect to Copitrak, the fact remains that there is a strong likelihood of consumer confusion as a result of its use of the Copitrack metatag. The degree of care exercised by consumers could lead to initial interest confusion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Medcor, Inc. v. Garcia
N.D. Illinois, 2022
Anderson v. Jeffreys
N.D. Illinois, 2021

Cite This Page — Counsel Stack

Bluebook (online)
300 F.3d 808, 63 U.S.P.Q. 2d (BNA) 2018, 2002 U.S. App. LEXIS 16207, 2002 WL 1837776, Counsel Stack Legal Research, https://law.counselstack.com/opinion/promatek-industries-ltd-v-equitrac-corporation-ca7-2002.